The 21-Gene Recurrence Score in Male Breast Cancer.

about

The 21-Gene Recurrence Score in Male Breast Cancer.

Item

http://www.wikidata.org/entity/Q52665411

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The 21-Gene Recurrence Score in Male Breast Cancer.

@en

The 21-Gene Recurrence Score in Male Breast Cancer.

@nl

type

Item

label

The 21-Gene Recurrence Score in Male Breast Cancer.

@en

The 21-Gene Recurrence Score in Male Breast Cancer.

@nl

prefLabel

The 21-Gene Recurrence Score in Male Breast Cancer.

@en

The 21-Gene Recurrence Score in Male Breast Cancer.

@nl

P1476

The 21-Gene Recurrence Score in Male Breast Cancer.

@en

P2093

Edi Brogi

http://www.w3.org/2001/XMLSchema#string

Gulisa Turashvili

http://www.w3.org/2001/XMLSchema#string

Hannah Y Wen

http://www.w3.org/2001/XMLSchema#string

Maura Dickler

http://www.w3.org/2001/XMLSchema#string

Monica Gonzalez-Loperena

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Multidisciplinary meeting on male breast cancer: summary and research recommendations

The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection.

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

Predictive and prognostic value of the 21-gene recurrence score in hormone receptor-positive, node-positive breast cancer.

Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.

P2888

s10434-018-6411-z

P304

1530-1535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-018-6411-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Larry Norton

Monica Morrow

P577

2018-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101388877

http://www.w3.org/2001/XMLSchema#string

P698

29520654

http://www.w3.org/2001/XMLSchema#string

P932

5930124

http://www.w3.org/2001/XMLSchema#string